Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
EV/Core EBITDA

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 19.4831.1331.3232.6710.70

What is the latest EV/Core EBITDA ratio of MEDICAMEN BIOTECH ?

The latest EV/Core EBITDA ratio of MEDICAMEN BIOTECH is 19.48 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202419.48
Mar202331.13
Mar202231.32
Mar202132.67
Mar202010.70

How is EV/Core EBITDA of MEDICAMEN BIOTECH Trending?

Years EV/Core EBITDA % Change
Mar2024 19.48
-37.42
Mar2023 31.13
-0.61
Mar2022 31.32
-4.13
Mar2021 32.67
205.33
Mar2020 10.7 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare EV/Core EBITDA ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹517.6 Cr -4.5% -8.4% -13.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,595.0 Cr 1.5% 0.9% 2% Stock Analytics
DIVIS LABORATORIES ₹174,635.0 Cr -0.5% -1.2% 45.5% Stock Analytics
CIPLA ₹126,894.0 Cr 7.2% 4.5% 2.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,685.0 Cr 3.5% 8.4% 16.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,373.0 Cr 3.7% -1.1% -6.8% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-4.5%

-8.4%

-13.9%

SENSEX

-1.6%

-3.4%

0.9%


You may also like the below Video Courses